tiprankstipranks
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market
WST
West Pharmaceutical Services
RESEARCH TOOLSreports
Want to see WST full AI Analyst Report?

West Pharmaceutical Services (WST) Income Statement

893 Followers

West Pharmaceutical Services Income Statement

Last quarter (Q1 2026), West Pharmaceutical Services's total revenue was $844.90M, an increase of 21.01% from the same quarter last year. In Q1, West Pharmaceutical Services's net income was $138.80M. See West Pharmaceutical Services’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.07B$ 2.89B$ 2.95B$ 2.89B$ 2.83B
Gross Profit
$ 1.10B$ 1.00B$ 1.13B$ 1.14B$ 1.17B
Operating Expenses
$ 485.90M$ 407.60M$ 421.80M$ 375.40M$ 414.70M
Depreciation and Amortization
$ 124.40M$ 155.40M$ 137.30M$ 120.60M$ 122.30M
EBITDA
$ 723.60M$ 743.80M$ 844.10M$ 808.10M$ 879.70M
Operating Income
$ 617.40M$ 594.60M$ 710.90M$ 763.50M$ 758.70M
Other Income/Expenses
$ -2.10M$ 5.60M$ 4.80M$ -62.90M$ 10.30M
Pretax Income
$ 615.30M$ 600.20M$ 715.70M$ 700.60M$ 769.00M
Net Income
$ 493.70M$ 492.70M$ 593.40M$ 585.90M$ 661.80M
Per Share Metrics
Basic EPS
$ 6.83$ 6.75$ 7.99$ 7.88$ 8.90
Diluted EPS
$ 6.80$ 6.69$ 7.88$ 7.73$ 8.67
Weighted Average Shares Outstanding
 72.30M 73.00M 74.30M 74.40M 74.40M
Weighted Average Shares Outstanding (Diluted)
 72.70M 73.70M 75.30M 75.80M 76.30M
Currency in USD

West Pharmaceutical Services Earnings and Revenue History